The role of BDNF in the pathophysiology and treatment of schizophrenia

G Favalli, J Li, P Belmonte-de-Abreu, AHC Wong… - Journal of psychiatric …, 2012 - Elsevier
Brain Derived Neurotrophic Factor (BDNF) has been associated with the pathophysiology of
schizophrenia (SCZ). However, it remains unclear whether alterations in BDNF observed in …

Cancer in women

S Pecorelli, G Favalli, L Zigliani, F Odicino - International Journal of …, 2003 - Elsevier
Incidence, mortality and survival trends for the most frequent cancers affecting women are
presented on a worldwide basis. Data sources are represented by several different cancer …

[HTML][HTML] The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer

…, A Kobierska, N Colombo, G Favalli… - … England Journal of …, 1995 - Mass Medical Soc
Background Although the value of primary cytoreductive surgery for epithelial ovarian
cancer is beyond doubt, the value of debulking surgery after induction chemotherapy has …

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

…, JP Guastalla, R Despax, G Favalli… - Journal of Clinical …, 1996 - ascopubs.org
PURPOSE Topotecan is a topoisomerase I inhibitor with preclinical activity against various
tumor types. We conducted a large multicenter phase II study with topotecan in ovarian …

[HTML][HTML] Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial

…, F Spina, M Melpignano, P Zola, G Favalli… - British journal of …, 2006 - nature.com
Patients with high-risk endometrial carcinoma (stage IcG3, IIG3 with myometrial invasion>
50%, and III) receive adjuvant therapy after surgery but it is not clear whether radiotherapy …

Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial

…, I Floriani, RS Rossi, R Grassi, G Favalli… - Journal of the …, 2005 - academic.oup.com
Background: The role of systematic aortic and pelvic lymphadenectomy in patients with
optimally debulked advanced ovarian cancer is unclear and has not been addressed by …

Evidence of cortical inhibitory deficits in major depressive disorder

AJ Levinson, PB Fitzgerald, G Favalli… - Biological …, 2010 - Elsevier
BACKGROUND: Several lines of evidence suggest that major depressive disorder is
associated with deficits in γ-aminobutyric acid (GABA) inhibitory neurotransmission …

[HTML][HTML] Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological …

…, F Zanaboni, AJ Lacave, R Fontanelli, G Favalli… - Annals of …, 2003 - Elsevier
Background Combination chemotherapy yields better response rates which do not always
lead to a survival advantage. The aim of this study was to investigate whether the reported …

Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.

…, M Tonato, F Cognetti, E Cortesi, G Favalli… - Journal of Clinical …, 1991 - ascopubs.org
Ondansetron (OND) is a new 5-HT3 receptor antagonist that give complete protection from
emesis/nausea in approximately 50% of cisplatin (CDDP)-treated patients. To evaluate if …

[HTML][HTML] Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate …

…, V Torri, S Marsoni, C Bonazzi, S Chiari, G Favalli… - Annals of oncology, 1995 - Elsevier
Summary Background From 1983 to 1990, 271 consecutive patients with stage I ovarian
cancer entered two randomised trials, aimed at assessing the role of adjuvant chemotherapy …